Piramal Pharma P/B Ratio

Current P/B Ratio
2.92
Moderate Valuation
High - Premium to book value, growth expectations or asset-light model

Piramal Pharma (PPLPHARMA) P/B ratio is 2.92 (Moderate), book value per share ₹61.51 vs Healthcare average P/B of -0.31 — High - Premium to book value, growth expectations or asset-light model. For live price, earnings yield and the full fundamental profile, see PPLPHARMA screener.

Current Valuation Metrics

P/B Ratio 2.92
Current Price ₹181.27
Book Value/Share ₹61.51
Exchange NSE

Book Value Breakdown (2026)

Balance Sheet Components
Total Equity ₹8,163 Cr
Share Capital ₹1,327 Cr
Reserves & Surplus ₹6,836 Cr
Outstanding Shares 1,327,000,000
Book Value per Share ₹61.51

Valuation Signal

Signal Overvalued
Historical Avg 2.93
Historical Range 1.98 - 4.45
Percentile 60.0%

Sector Context

Sector Average -0.31
Sector Median 0.57
Sector Rank #11 of 50
Sector Percentile 22.0%

PPLPHARMA P/B Ratio — Valuation Insights & Book Value Analysis

Piramal Pharma price-to-book ratio interpretation, valuation status and historical context — current P/B 2.92 (Moderate). View PPLPHARMA 52-week chart for the annual high/low range and current price position.

  • Trading at premium to sector average PB of -0.31

Piramal Pharma P/B Ratio Historical Trend

PPLPHARMA annual price-to-book ratio — 5 years, book value per share and year-end price. P/B below 1.0 indicates the stock trades below net asset value. Review Piramal Pharma price earnings to evaluate earnings-based valuation against sector peers.

PPLPHARMA Historical P/B Ratio — Book Value Per Share & Year-End Price

Piramal Pharma annual P/B ratio, book value per share (₹), year-end price and total equity in ₹ Crores.

Year P/B Ratio Book Value/Share (₹) Year-end Price (₹) Total Equity (₹ Cr) Valuation
2026 2.95 ₹61.51 ₹181.27 ₹8,163 Moderate
2025 2.81 ₹61.37 ₹172.21 ₹8,126 Moderate
2024 4.45 ₹59.8 ₹266.25 ₹7,911 High
2023 2.45 ₹56.78 ₹138.85 ₹6,774 Moderate
2022 1.98 ₹56.47 ₹111.95 ₹6,697 Moderate

PPLPHARMA vs Healthcare Peers — P/B Ratio Comparison

Piramal Pharma P/B 2.92 vs Healthcare average -0.31, median 0.57 — range -14.47–1.1.

Sector Average
-0.31
Sector Median
0.57
Lowest P/B
-14.47
Highest P/B
1.1
Companies
50
Company Symbol P/B Ratio Market Cap (₹ Cr) Valuation
Rekvina Laboratories VINRKLB -14.47 ₹18 Low
Span Divergent SDL -6.32 ₹19 Low
Parmax Pharma PARMAX -5.61 ₹39 Low
Oxygenta Pharmaceutical OXYGENTAPH -5.54 ₹203 Low
Satiate Agri SATAGRI -3.39 ₹8 Low
Adline Chem Lab ADLINE -3.03 ₹5 Low
Bharat Immunologicals BIBCL -2.22 ₹72 Low
Krebs Biochemicals & Ind… KREBSBIO -0.71 ₹115 Low
Cresanto Global CRESANTO -0.7 ₹2 Low
Vivimed Labs VIVIMEDLAB -0.5 ₹44 Low